STAND. COM. REP. NO. 664

Honolulu, Hawaii

, 2005

RE: H.B. No. 31

H.D. 2

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Third State Legislature

Regular Session of 2005

State of Hawaii

Sir:

Your Committee on Judiciary, to which was referred H.B. No. 31, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"

begs leave to report as follows:

The purpose of this bill is to require manufacturers of prescription drugs to provide quarterly reports that disclose:

(1) The average wholesale price;

(2) The wholesale acquisition cost;

(3) The average manufacturer price; and

(4) The best price of prescription drugs dispensed in the State.

The AARP Hawaii, ILWU Local 142, Kokua Council, and several concerned individuals testified in support of this bill.

Your Committee finds that the knowledge gained by these quarterly reports could assist the State to better negotiate discounts for State prescription drug programs.

 

 

Your Committee has amended this bill by:

(1) Moving oversight of the prescription drug price reporting program from the Department of Health to Department of Human Services; and

(2) Making technical, nonsubstantive changes for style, clarity, and consistency.

As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 31, H.D. 1, as amended herein, and recommends that it be referred to the Committee on Finance in the form attached hereto as H.B. No. 31, H.D. 2.

 

Respectfully submitted on behalf of the members of the Committee on Judiciary,

 

____________________________

SYLVIA LUKE, Chair